New data from landmark analysis presented today report a decreased risk of disease recurrence or death in patients with resectable NSCLC who received...

Data from a late-stage study shows that SMMT's experimental antibody beat Keytruda in a head-to-head setting in treating certain patients with NSCLC.

FRIDAY, Sept. 13, 2024 -- Tusamitamab ravtansine (tusa rav), an immunoconjugate, does not improve progression-free survival (PFS) in patients with...

MONDAY, Sept. 16, 2024 -- For patients undergoing treatment for certain types of cancer, artificial intelligence (AI) can use electrocardiographic...

Study reveals recent PM2.5 exposure increases lung cancer risk in non-smoking women, with significant EGFR mutations found in late-stage diagnoses.

Study reveals recent PM2.5 exposure increases lung cancer risk in non-smoking women, with significant EGFR mutations found in late-stage diagnoses.

The clinical study will evaluate MRK's experimental antibody treatment in patients with diabetic macular edema, a major cause of vision loss.

With this latest approval, JNJ's Tremfya is approved for a total of three immunology indications.

With this latest approval, JNJ's Tremfya is approved for a total of three immunology indications.

FRIDAY, Sept. 6, 2024 -- A computed tomography (CT)-based radiomics nomogram model can achieve favorable efficacy for predicting low-risk patients...